A model-based patient selection tool to identify who may be at risk of exceeding dose tolerances during pancreatic SBRT.

CONCLUSIONS: Our model-based patient selection tool is able to predict who might be at risk of exceeding dose-constraints during SBRT. It is a promising tool to tailor LAPC treatments, e.g. by employing online adaptive SBRT; and hence, to minimize toxicity of patients being at risk.
PMID: 31606227 [PubMed - as supplied by publisher]

Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - October 8, 2019 Category: Radiology Authors: Magallon-Baro A, Granton PV, Milder MTW, Loi M, Zolnay AG, Nuyttens JJ, Hoogeman MS Tags: Radiother Oncol Source Type: research